| Recruiting | The GRoceries Aimed at Increasing Nutrition Study NCT07167004 | University of Pennsylvania | N/A |
| Recruiting | Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients NCT06049420 | West Virginia School of Osteopathic Medicine | N/A |
| Recruiting | Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus NCT05028140 | EMS | Phase 3 |
| Active Not Recruiting | Effectiveness of an mHealth Mobile App NCT06387433 | Dow University of Health Sciences | N/A |
| Unknown | Passive Stretching Versus Electrical Stimulation on Glucose Level, in Elderly With Type II Diabetes NCT06245252 | Mona Mohamed Abdelkhalek | N/A |
| Recruiting | Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT NCT05708859 | Matthew J. Budoff | Phase 4 |
| Recruiting | Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects NCT05176210 | Pharmasaga Co. Ltd. | Phase 1 |
| Recruiting | The Effects of Raspberry Leaf Tea on Blood Glucose Control NCT06385626 | University of Reading | N/A |
| Completed | Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-admi NCT05881213 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 NCT05741437 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Burger Allen Exercises in Knee OA With Type II Diabetes NCT05878587 | Riphah International University | N/A |
| Unknown | Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study NCT05272839 | Antenna Foundation | N/A |
| Unknown | A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the NCT05108350 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Unknown | A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers NCT05120219 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Completed | Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on t NCT04893135 | Centre Hospitalier Sud Francilien | N/A |
| Completed | Dietary Approaches to Stop Hypertension for Diabetes NCT04286555 | Johns Hopkins University | N/A |
| Completed | A Study to Investigate the PK and Safety of CKD-393 NCT04768673 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Mass Balance and Biotransformation of [14C]HSK7653 in Human NCT04540016 | Sichuan Haisco Pharmaceutical Group Co., Ltd | Phase 1 |
| Completed | Postbiotic MBS and Metformin Combination in Patients With T2DM NCT04639492 | Microbio Co Ltd | N/A |
| Completed | Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes NCT06224803 | Global Preventive Medicine Biotech Co., Ltd. | N/A |
| Completed | Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients NCT04499846 | Lille Catholic University | — |
| Completed | INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diab NCT04461405 | Oregon Health and Science University | N/A |
| Recruiting | Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. NCT05074732 | Health Service Executive, Ireland | — |
| Completed | SOKARY Mobile Application With Type II Diabetes NCT04843592 | Magda Bayoumi | — |
| Completed | Peer Support Dyads in Churches NCT03463941 | Duke University | N/A |
| Unknown | Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes NCT04715776 | Taipei Medical University WanFang Hospital | N/A |
| Unknown | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults NCT03646799 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging NCT03498001 | Centre Hospitalier Universitaire Dijon | N/A |
| Completed | Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin NCT02984644 | The University of Texas Health Science Center at San Antonio | Phase 3 |
| Completed | Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects NCT03027960 | Yale University | Phase 1 |
| Completed | Social Incentives to Improve Diabetes NCT02961192 | University of Pennsylvania | N/A |
| Unknown | Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to Humans NCT02974699 | Wayne State University | EARLY_Phase 1 |
| Unknown | Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUD NCT03024788 | Zhongda Hospital | — |
| Completed | Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes NCT02914743 | Massachusetts General Hospital | N/A |
| Unknown | Salivary Transcriptome Biomarkers for Early Diabetes Detection NCT02673762 | PeriRx | — |
| Unknown | Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics NCT01001962 | Aristotle University Of Thessaloniki | Phase 4 |
| Completed | Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study NCT02471794 | Duke University | N/A |
| Completed | Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes NCT02586129 | Yuhan Corporation | Phase 3 |
| Completed | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) NCT02947620 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformi NCT02429258 | AstraZeneca | Phase 4 |
| Completed | Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility NCT02214056 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Clinical Trial for PB-119 in Healthy Subjects (Phase I) NCT02084251 | PegBio Co., Ltd. | Phase 1 |
| Terminated | Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers NCT02015910 | Georgetown University | Phase 4 |
| Completed | Initial Clinical Evaluation of an Endoscopic Therapy for Type 2 Diabetes NCT01927562 | Fractyl Health Inc. | N/A |
| Completed | Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Exper NCT02637622 | Johns Hopkins Bloomberg School of Public Health | — |
| Completed | Measuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst Scaling NCT02637609 | Johns Hopkins Bloomberg School of Public Health | — |
| Terminated | Fatty Liver Study in Patients With Type II Diabetes NCT02365233 | The University of Texas Medical Branch, Galveston | Phase 4 |
| Terminated | Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes NCT01804777 | University of New Mexico | EARLY_Phase 1 |
| Completed | Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior NCT01801254 | University of Rochester | Phase 1 |
| Unknown | Type II Diabetes Influence on Left Ventricular Remodeling and Outcomes in Patients Undergoing Aortic Valve Rep NCT01862237 | Hospices Civils de Lyon | N/A |
| Completed | Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration NCT01698528 | Joslin Diabetes Center | N/A |
| Completed | The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy NCT02127762 | Ottawa Hospital Research Institute | N/A |
| Withdrawn | The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients NCT04569214 | Boston Therapeutics | Phase 2 |
| Completed | Activator and Type II Diabetics NCT01782092 | Life University | — |
| Unknown | Diabetes Mellitus Community Based Screening in Minority Populations NCT01591525 | Ethnicity and Disease Community Empowerment Center | — |
| Completed | Periodontal Treatment Response in Type II Diabetic Patients NCT01881074 | University of Florida | — |
| Unknown | Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors NCT01564498 | University of Guelph | Phase 1 |
| Completed | Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 NCT01619332 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Intensive Discharge Intervention in Diabetes NCT02122926 | Brigham and Women's Hospital | N/A |
| Completed | Biospecimens for Identification of Diseases of the Pancreas. NCT01392027 | University of Michigan | N/A |
| Completed | The Effect of Gastric Bypass Surgery on Diabetes NCT01330251 | University of Oulu | — |
| Completed | Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity NCT00985114 | Morphic Medical Inc. | N/A |
| Completed | Fracture Risk With Thiazolidinediones NCT01055223 | GlaxoSmithKline | — |
| Completed | Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes NCT00856908 | AstraZeneca | Phase 2 |
| Completed | Outreach for Diabetes Cure NCT01384045 | University of Colorado, Denver | N/A |
| Completed | To Evaluate 24-hr Glucose After OD vs BD AZD1656 NCT00819884 | AstraZeneca | Phase 1 |
| Unknown | Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes NCT00694278 | Ferzli, George S., M.D. F.A.C.S. | — |
| Completed | To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fastin NCT00882882 | Sandoz | Phase 1 |